NCI-NCI-26-001: 2026 DFC National Community Anti-Drug Institute Notice of Funding Opportunity
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of National Drug Control Policy notices from 2026.
Office of National Drug Control Policy offered grants of up to $2.5 million to nonprofits. It expected to make one award. Applications closed on May 1, 2026.
From the official notice on Grants.gov, last changed March 11, 2026. Checked November 7, 2026.
- Award ceiling$2.5 million
- Expected awards1
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | March 11, 2026 |
|---|---|
| Deadline | May 1, 2026 |
| Archived by Grants.gov | May 31, 2026 |
Who can apply
This opportunity was open to nonprofits.
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
ONDCP encourages applications from national nonprofit institutions/organizations and strongly encourages applicants to partner with organizations with applicable expertise and experience to fulfill all aspects of the NCI. Applications must demonstrate expertise in youth substance use prevention and broad, national-level experience in community anti-drug coalitions under section 1032 of the National Narcotics Leadership Act of 1988 (21 U.S.C. § 1532).
Is this a realistic fit?
- Past DFC NATIONAL COMMUNITY ANTIDRUG COALITION INSTITUTE awards averaged $2.5 million; this notice allows up to $2.5 million per award.
- Most of the program's money (100% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The Office of National Drug Control Policy (ONDCP), Executive Office of the President (EOP), is seeking applications from any national nonprofit organization that represents, provides technical assistance and training to, and has special expertise and broad, national-level experience in community anti-drug coalitions. To fully operationalize the NCI, partnership amongst applicants is strongly encouraged.
Who has won DFC NATIONAL COMMUNITY ANTIDRUG COALITION INSTITUTE grants before
From fiscal 2021 to 2025, DFC NATIONAL COMMUNITY ANTIDRUG COALITION INSTITUTE (95.003) awarded $10.0 million across 4 grant awards, an average of $2.5 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Cadca | Virginia | 4 | $10.0 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is NCI-NCI-26-001 still open?
No. It closed on May 1, 2026.
Who can apply for 2026 DFC National Community Anti-Drug Institute Notice of Funding Opportunity?
Office of National Drug Control Policy accepted applications from nonprofits. The notice adds further conditions, so read its eligibility section.
What is the deadline for 2026 DFC National Community Anti-Drug Institute Notice of Funding Opportunity?
Closed May 1, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $2.5 million each.
Who has won DFC NATIONAL COMMUNITY ANTIDRUG COALITION INSTITUTE grants before?
The largest recipients over five fiscal years were Cadca. The program made 4 awards worth $10.0 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)